China Branded Generics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Branded Generics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Branded Generics market. Detailed analysis of key players, along with key growth strategies adopted by Branded Generics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Mylan NV

    • Qilu Pharmaceutical Co, Ltd

    • Eva Pharmaceutical Industries

    • Shanghai Fosun Pharmaceutical Group

    • Pfizer

    • Aspen Pharmacare Holding

    • Abbott Laboratories

    • Valeant Pharmaceuticals International

    By Type:

    • Oral

    • Parenteral

    • Other

    By End-User:

    • Oncology

    • Cardiovascular Diseases

    • Diabetes

    • Neurology

    • Gastrointestinal Diseases

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Branded Generics Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Branded Generics Market Size and Growth Rate of Oral from 2016 to 2027

    • 1.3.2 China Branded Generics Market Size and Growth Rate of Parenteral from 2016 to 2027

    • 1.3.3 China Branded Generics Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Branded Generics Market Size and Growth Rate of Oncology from 2016 to 2027

    • 1.4.2 China Branded Generics Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

    • 1.4.3 China Branded Generics Market Size and Growth Rate of Diabetes from 2016 to 2027

    • 1.4.4 China Branded Generics Market Size and Growth Rate of Neurology from 2016 to 2027

    • 1.4.5 China Branded Generics Market Size and Growth Rate of Gastrointestinal Diseases from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Branded Generics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Branded Generics by Major Types

    • 3.4.1 Market Size and Growth Rate of Oral

    • 3.4.2 Market Size and Growth Rate of Parenteral

    • 3.4.3 Market Size and Growth Rate of Other

    4 Segmentation of Branded Generics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Branded Generics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Branded Generics in Oncology

    • 4.4.2 Market Size and Growth Rate of Branded Generics in Cardiovascular Diseases

    • 4.4.3 Market Size and Growth Rate of Branded Generics in Diabetes

    • 4.4.4 Market Size and Growth Rate of Branded Generics in Neurology

    • 4.4.5 Market Size and Growth Rate of Branded Generics in Gastrointestinal Diseases

    5 Market Analysis by Regions

    • 5.1 China Branded Generics Production Analysis by Regions

    • 5.2 China Branded Generics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Branded Generics Landscape Analysis

    • 6.1 North China Branded Generics Landscape Analysis by Major Types

    • 6.2 North China Branded Generics Landscape Analysis by Major End-Users

    7 Central China Branded Generics Landscape Analysis

    • 7.1 Central China Branded Generics Landscape Analysis by Major Types

    • 7.2 Central China Branded Generics Landscape Analysis by Major End-Users

    8 South China Branded Generics Landscape Analysis

    • 8.1 South China Branded Generics Landscape Analysis by Major Types

    • 8.2 South China Branded Generics Landscape Analysis by Major End-Users

    9 East China Branded Generics Landscape Analysis

    • 9.1 East China Branded Generics Landscape Analysis by Major Types

    • 9.2 East China Branded Generics Landscape Analysis by Major End-Users

    10 Northeast China Branded Generics Landscape Analysis

    • 10.1 Northeast China Branded Generics Landscape Analysis by Major Types

    • 10.2 Northeast China Branded Generics Landscape Analysis by Major End-Users

    11 Southwest China Branded Generics Landscape Analysis

    • 11.1 Southwest China Branded Generics Landscape Analysis by Major Types

    • 11.2 Southwest China Branded Generics Landscape Analysis by Major End-Users

    12 Northwest China Branded Generics Landscape Analysis

    • 12.1 Northwest China Branded Generics Landscape Analysis by Major Types

    • 12.2 Northwest China Branded Generics Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Mylan NV

      • 13.1.1 Mylan NV Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Qilu Pharmaceutical Co, Ltd

      • 13.2.1 Qilu Pharmaceutical Co, Ltd Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Eva Pharmaceutical Industries

      • 13.3.1 Eva Pharmaceutical Industries Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Shanghai Fosun Pharmaceutical Group

      • 13.4.1 Shanghai Fosun Pharmaceutical Group Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Pfizer

      • 13.5.1 Pfizer Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Aspen Pharmacare Holding

      • 13.6.1 Aspen Pharmacare Holding Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Abbott Laboratories

      • 13.7.1 Abbott Laboratories Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Valeant Pharmaceuticals International

      • 13.8.1 Valeant Pharmaceuticals International Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Branded Generics Market Size and Growth Rate of Oral from 2016 to 2027

    • Figure China Branded Generics Market Size and Growth Rate of Parenteral from 2016 to 2027

    • Figure China Branded Generics Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Branded Generics Market Size and Growth Rate of Oncology from 2016 to 2027

    • Figure China Branded Generics Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

    • Figure China Branded Generics Market Size and Growth Rate of Diabetes from 2016 to 2027

    • Figure China Branded Generics Market Size and Growth Rate of Neurology from 2016 to 2027

    • Figure China Branded Generics Market Size and Growth Rate of Gastrointestinal Diseases from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Branded Generics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Branded Generics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Branded Generics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Branded Generics by Different Types from 2016 to 2027

    • Table Consumption Share of Branded Generics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Oral

    • Figure Market Size and Growth Rate of Parenteral

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Branded Generics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Branded Generics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Diabetes

    • Figure Market Size and Growth Rate of Neurology

    • Figure Market Size and Growth Rate of Gastrointestinal Diseases

    • Table China Branded Generics Production by Regions

    • Table China Branded Generics Production Share by Regions

    • Figure China Branded Generics Production Share by Regions in 2016

    • Figure China Branded Generics Production Share by Regions in 2021

    • Figure China Branded Generics Production Share by Regions in 2027

    • Table China Branded Generics Consumption by Regions

    • Table China Branded Generics Consumption Share by Regions

    • Figure China Branded Generics Consumption Share by Regions in 2016

    • Figure China Branded Generics Consumption Share by Regions in 2021

    • Figure China Branded Generics Consumption Share by Regions in 2027

    • Table North China Branded Generics Consumption by Types from 2016 to 2027

    • Table North China Branded Generics Consumption Share by Types from 2016 to 2027

    • Figure North China Branded Generics Consumption Share by Types in 2016

    • Figure North China Branded Generics Consumption Share by Types in 2021

    • Figure North China Branded Generics Consumption Share by Types in 2027

    • Table North China Branded Generics Consumption by End-Users from 2016 to 2027

    • Table North China Branded Generics Consumption Share by End-Users from 2016 to 2027

    • Figure North China Branded Generics Consumption Share by End-Users in 2016

    • Figure North China Branded Generics Consumption Share by End-Users in 2021

    • Figure North China Branded Generics Consumption Share by End-Users in 2027

    • Table Central China Branded Generics Consumption by Types from 2016 to 2027

    • Table Central China Branded Generics Consumption Share by Types from 2016 to 2027

    • Figure Central China Branded Generics Consumption Share by Types in 2016

    • Figure Central China Branded Generics Consumption Share by Types in 2021

    • Figure Central China Branded Generics Consumption Share by Types in 2027

    • Table Central China Branded Generics Consumption by End-Users from 2016 to 2027

    • Table Central China Branded Generics Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Branded Generics Consumption Share by End-Users in 2016

    • Figure Central China Branded Generics Consumption Share by End-Users in 2021

    • Figure Central China Branded Generics Consumption Share by End-Users in 2027

    • Table South China Branded Generics Consumption by Types from 2016 to 2027

    • Table South China Branded Generics Consumption Share by Types from 2016 to 2027

    • Figure South China Branded Generics Consumption Share by Types in 2016

    • Figure South China Branded Generics Consumption Share by Types in 2021

    • Figure South China Branded Generics Consumption Share by Types in 2027

    • Table South China Branded Generics Consumption by End-Users from 2016 to 2027

    • Table South China Branded Generics Consumption Share by End-Users from 2016 to 2027

    • Figure South China Branded Generics Consumption Share by End-Users in 2016

    • Figure South China Branded Generics Consumption Share by End-Users in 2021

    • Figure South China Branded Generics Consumption Share by End-Users in 2027

    • Table East China Branded Generics Consumption by Types from 2016 to 2027

    • Table East China Branded Generics Consumption Share by Types from 2016 to 2027

    • Figure East China Branded Generics Consumption Share by Types in 2016

    • Figure East China Branded Generics Consumption Share by Types in 2021

    • Figure East China Branded Generics Consumption Share by Types in 2027

    • Table East China Branded Generics Consumption by End-Users from 2016 to 2027

    • Table East China Branded Generics Consumption Share by End-Users from 2016 to 2027

    • Figure East China Branded Generics Consumption Share by End-Users in 2016

    • Figure East China Branded Generics Consumption Share by End-Users in 2021

    • Figure East China Branded Generics Consumption Share by End-Users in 2027

    • Table Northeast China Branded Generics Consumption by Types from 2016 to 2027

    • Table Northeast China Branded Generics Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Branded Generics Consumption Share by Types in 2016

    • Figure Northeast China Branded Generics Consumption Share by Types in 2021

    • Figure Northeast China Branded Generics Consumption Share by Types in 2027

    • Table Northeast China Branded Generics Consumption by End-Users from 2016 to 2027

    • Table Northeast China Branded Generics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Branded Generics Consumption Share by End-Users in 2016

    • Figure Northeast China Branded Generics Consumption Share by End-Users in 2021

    • Figure Northeast China Branded Generics Consumption Share by End-Users in 2027

    • Table Southwest China Branded Generics Consumption by Types from 2016 to 2027

    • Table Southwest China Branded Generics Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Branded Generics Consumption Share by Types in 2016

    • Figure Southwest China Branded Generics Consumption Share by Types in 2021

    • Figure Southwest China Branded Generics Consumption Share by Types in 2027

    • Table Southwest China Branded Generics Consumption by End-Users from 2016 to 2027

    • Table Southwest China Branded Generics Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Branded Generics Consumption Share by End-Users in 2016

    • Figure Southwest China Branded Generics Consumption Share by End-Users in 2021

    • Figure Southwest China Branded Generics Consumption Share by End-Users in 2027

    • Table Northwest China Branded Generics Consumption by Types from 2016 to 2027

    • Table Northwest China Branded Generics Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Branded Generics Consumption Share by Types in 2016

    • Figure Northwest China Branded Generics Consumption Share by Types in 2021

    • Figure Northwest China Branded Generics Consumption Share by Types in 2027

    • Table Northwest China Branded Generics Consumption by End-Users from 2016 to 2027

    • Table Northwest China Branded Generics Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Branded Generics Consumption Share by End-Users in 2016

    • Figure Northwest China Branded Generics Consumption Share by End-Users in 2021

    • Figure Northwest China Branded Generics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Mylan NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan NV

    • Figure Sales and Growth Rate Analysis of Mylan NV

    • Figure Revenue and Market Share Analysis of Mylan NV

    • Table Product and Service Introduction of Mylan NV

    • Table Company Profile and Development Status of Qilu Pharmaceutical Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qilu Pharmaceutical Co, Ltd

    • Figure Sales and Growth Rate Analysis of Qilu Pharmaceutical Co, Ltd

    • Figure Revenue and Market Share Analysis of Qilu Pharmaceutical Co, Ltd

    • Table Product and Service Introduction of Qilu Pharmaceutical Co, Ltd

    • Table Company Profile and Development Status of Eva Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eva Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Eva Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Eva Pharmaceutical Industries

    • Table Product and Service Introduction of Eva Pharmaceutical Industries

    • Table Company Profile and Development Status of Shanghai Fosun Pharmaceutical Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Fosun Pharmaceutical Group

    • Figure Sales and Growth Rate Analysis of Shanghai Fosun Pharmaceutical Group

    • Figure Revenue and Market Share Analysis of Shanghai Fosun Pharmaceutical Group

    • Table Product and Service Introduction of Shanghai Fosun Pharmaceutical Group

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Aspen Pharmacare Holding

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aspen Pharmacare Holding

    • Figure Sales and Growth Rate Analysis of Aspen Pharmacare Holding

    • Figure Revenue and Market Share Analysis of Aspen Pharmacare Holding

    • Table Product and Service Introduction of Aspen Pharmacare Holding

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Valeant Pharmaceuticals International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International

    • Table Product and Service Introduction of Valeant Pharmaceuticals International


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.